| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Capecitabine | FAERS: 5 | OFFSIDES US FAERS | |
| 2 | Diphenhydramine | FAERS: 3 | US FAERS | |
| 3 | NuvaRing | FAERS: 2 | US FAERS | |
| 4 | rofecoxib | FAERS: 2 | US FAERS | |
| 5 | Adzenys XR-ODT | FAERS: 1 | US FAERS | |
| 6 | Carbamazepine | FAERS: 1 | US FAERS | |
| 7 | Citalopram | FAERS: 1 | US FAERS | |
| 8 | Clozapine | FAERS: 1 | US FAERS | |
| 9 | Diphenhydramine | FAERS: 1 | US FAERS | |
| 10 | contrast agent BR1 | FAERS: 1 | US FAERS | |
| 11 | Ganciclovir | OFFSIDES | ||
| 12 | Guanfacine | OFFSIDES | ||
| 13 | Trimethoprim | OFFSIDES | ||
| 14 | ambrisentan | Canada Vigilance: 1 | Canada Vigilance | |
| 15 | chlordiazepoxide, clidinium drug combination | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.